Cubist Pharmaceuticals, Inc. (CBST) Tops Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street set for weekly gains with earnings, inflation data on tap
- Oil falls as Trump comments on Iran talks ease supply fears
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts CBST Hot Sheet
Price: $101.94 --0%
Financial Fact:
Total costs and expenses: 241.35M
Today's EPS Names:
HOVR, VFS, PGR, More
Financial Fact:
Total costs and expenses: 241.35M
Today's EPS Names:
HOVR, VFS, PGR, More
Join SI Premium – FREE
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) reported Q2 EPS of $0.42, $0.04 better than the analyst estimate of $0.38. Revenue for the quarter came in at $258.8 million versus the consensus estimate of $254.93 million.
For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.
For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Top AI Semiconductor Stocks According to Stifel Analysis
- Alibaba ADR climbs on analyst upgrades, AI momentum
- StoneX Reiterates Buy Rating on Marcus Corp. (MCS)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
